甾醇调控元件结合蛋白(SREBP)在代谢性炎症综合征中的研究进展

doi:10.16352/j.issn.1001-6325.2026.09.1287

基础医学与临床 ›› 2026, Vol. 46 ›› Issue (9): 1287-1292.doi: 10.16352/j.issn.1001-6325.2026.09.1287

甾醇调控元件结合蛋白(SREBP)在代谢性炎症综合征中的研究进展

张意¹, 杨丽娟^1,2, 王平乐^1*

1.内蒙古医科大学中医学院,内蒙古呼和浩特 010107;
2.内蒙古自治区中医医院风湿病科,内蒙古呼和浩特 010020

收稿日期:2025-09-07 修回日期:2025-11-26 出版日期:2026-09-05 发布日期:2026-08-18
通讯作者: ^*wangpingle2007@163.com
基金资助:
内蒙古自治区卫生健康首府地区公立医院高水平临床专科建设科技计划(2023SGGZ058)

Research progress on the mechanism of action of sterol regulatory element-binding protein(SREBP) in metabolic inflammatory syndrome

ZHANG Yi¹, YANG Lijuan^1,2, WANG Pingle^1*

1. Coolege of Traditional Chinese medicine College, Inner Mongolia Medical University, Hohhot 010107;
2. Department of Rheumatology, Inner Mangolia Autonmous Region Hospital of Traditional Chinese medicine, Hohhot 010102, China

Received:2025-09-07 Revised:2025-11-26 Online:2026-09-05 Published:2026-08-18
Contact: ^*wangpingle2007@163.com

摘要/Abstract

摘要： 甾醇调节元件结合蛋白(SREBPs)作为细胞调节脂肪代谢的关键转录因子,在代谢性炎症综合征(MIS)发生发展中扮演重要角色。长期高脂肪摄入下,SREBPs表达水平异常,通过调控尿酸代谢、血管内皮细胞(VEC)增殖、免疫细胞、NF-κB／NLRP3信号通路活性等多条信号通路参与MIS的发生发展。此外,SREBP的过度激活会导致慢性炎性反应,降低机体调节炎性反应能力。

关键词: 甾醇调控元件结合蛋白(SREBP), 代谢性炎症综合征, 痛风, NLRP3炎性小体, 核因子κB(NF-κB)

Abstract: Sterol regulatory element-binding proteins(SREBPs), key transcription factors in cellular lipid metabolism regulation, play a significant role in the development of metabolic inflammatory response syndrome(MIS). Under prolonged high-fat intake, aberrant expression levels of SREBPs contribute to the pathogenesis of MIS by modulating multiple signaling pathways, including uric acid metabolism, vascular endothelial cell(VEC) proliferation, immune cell activity, and NF-κB/NLRP3 signaling pathway. Furthermore, excessive activation of SREBPs leads to chronic inflammation and impairs the body's ability to regulate inflammation.

Key words: sterol regulatory element-binding protein(SREBP), metabolic inflammatory syndrome, gout, NLRP3 inflammasome, nuclear factor-κB(NF-κB)

中图分类号:

R589.2

张意, 杨丽娟, 王平乐. 甾醇调控元件结合蛋白(SREBP)在代谢性炎症综合征中的研究进展[J]. 基础医学与临床, 2026, 46(9): 1287-1292.

ZHANG Yi, YANG Lijuan, WANG Pingle. Research progress on the mechanism of action of sterol regulatory element-binding protein(SREBP) in metabolic inflammatory syndrome[J]. Basic & Clinical Medicine, 2026, 46(9): 1287-1292.

参考文献

[1] Wu Y,Song W,Su M,et al.The role of cholesterol metabolism and its regulation in tumor development[J].Cancer Med,2025,14:e70783.doi: 10.1002/cam4.70783.
[2] Barbhuiya PA,Yoshitomi R,Pathak MP.Understanding the link between sterol regulatory element binding protein(SREBPs)and metabolic dysfunction associated steatotic liver disease(MASLD)[J].Curr Obes Rep,2025,14:36.doi: 10.1007/s13679-025-00626-y.
[3] Bergentall M,Tremaroli V,Sun C,et al.Gut microbiota mediates SREBP-1c-driven hepatic lipogenesis and steatosis in response to zero-fat high-sucrose diet[J].Mol Metab,2025,97:102162.doi: 10.1016/j.molmet.
[4] Stachowicz A,Czepiel K,Wiśniewska A,et al.Mitochon-dria-targeted hydrogen sulfide donor reduces fatty liver and obesity in mice fed a high fat diet by inhibiting de novo lipogenesis and inflammation via mTOR/SREBP-1 and NF-κB signaling pathways[J].Pharmacol Res,2024,209:107428.doi: 10.1016/j.phrs.2024.107428.
[5] Ouyang N,Gan H,He Q,et al.Dysfunction of cholesterol sensor SCAP promotes inflammation activation in THP-1 macrophages[J].Exp Cell Res,2018,367:162-169.
[6] Lee JH, Lee SH, Lee EH,et al.SCAP deficiency facilitates obesity and insulin resistance through shifting adipose tissue macrophage polarization[J].J Adv Res,2023,45:1-13.
[7] Zhang X,Liu J.Regulating lipid metabolism in gout:a new perspective with therapeutic potential[J].Int J Gen Med,2024,17:5203-5217.
[8] Kawamura S,Matsushita Y,Kurosaki S,et al.Inhibiting SCAP/SREBP exacerbates liver injury and carcinogenesis in murine nonalcoholic steatohepatitis[J].J Clin Invest,2022,132:e151895.doi: 10.1172/JCI151895.
[9] 黄艳,袁放.不同年龄段痛风发生代谢相关脂肪性肝病的影响因素研究[J].现代医药卫生,2025,41:65-67.
[10] Chen B,Bao R,Pan J,et al.Taurine alleviates dysfunction of cholesterol metabolism under hyperuricemia by inhibiting A2AR-SREBP-2/CREB/HMGCR axis[J].J Lipid Res,2025,66:100746. doi: 10.1016/j.jlr.2025.100746.
[11] Zhou R,Stouffer GA,Frishman WH.Cholesterol paradigm and beyond in atherosclerotic cardiovascular disease:cholesterol,sterol regulatory element-binding protein,inflammation,and vascular cell mobilization in vasculopathy[J].Cardiol Rev,2022,30:267-273.
[12] Chen Z,Martin M,Li Z,et al.Endothelial dysfunction:the role of sterol regulatory element-binding protein-induced NOD-like receptor family pyrin domain-containing protein 3 inflammasome in atherosclerosis[J].Curr Opin Lipidol,2014,25:339-349.
[13] Zhao Z,Zhao Y,Zhang Y,et al.Gout-induced endothelial impairment:The role of SREBP2 transactivation of YAP[J].FASEB J,2021,35:e21613.doi: 10.1096/fj.202100337R.
[14] Cheng Y,Manabe I,Hayakawa S,et al.Caspase-11 contributes to site-1 protease cleavage and SREBP1 activation in the inflammatory response of macrophages[J].Front Immunol,2023,14:1009973.doi: 10.3389/fimmu.2023.1009973.
[15] Kusnadi A,Park S H,Yuan R,et al.The cytokine TNF promotes transcription factor SREBP activity and binding to Inflammatory genes to activate macrophages and limit tissue repair[J].Immunity,2019,51:241-257.
[16] Moretti J,Jia B,Hutchins Z,et al.Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome[J].Nat Immunol,2022,23:705-717.
[17] Luo W,Adamska J Z,Li C,et al.SREBP signaling is essential for effective B cell responses[J].Nat Immunol,2023,24:337-348.
[18] Xi Z,Shu L,Xiao L,et al.Macrophage NLRP3 inflammasome mediates the effects of sympathetic nerve on cardiac remodeling in obese rats[J].Mol Cell Endocrinol,2025,596:112417.doi: 10.1016/j.mce.2024.112417.
[19] Steffen TL,Stafford JD,Samson WK,et al.Nesfatin-1 is a regulator of inflammation with implications during obesity and metabolic syndrome[J].Appetite,2024,203:107669.doi: 10.1016/j.appet.2024.107669.
[20] Han N,Chang X,Yuan Z,et al.Expression and correlation analysis of silent information regulator 1(SIRT1),sterol regulatory element-binding protein-1(SREBP1),and pyroptosis factor in gestational diabetes mellitus[J].J Matern Fetal Neonatal Med,2024,37:2311809.doi:10.1080/14767058.2024.2311809.
[21] Varghese JF,Patel R,Yadav UCS.Sterol regulatory element binding protein(SREBP)-1 mediates oxidized low-density lipoprotein(oxLDL)induced macrophage foam cell formation through NLRP3 inflammasome activation[J].Cell Signal,2019,53:316-326.
[22] Guo C,Chi Z,Jiang D,et al.Cholesterol homeostatic regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome activation and cholesterol biosynthetic signaling in macrophages[J].Immunity,2018,49:842-856.
[23] Fei X,Huang J,Li F,et al.The Scap-SREBP1-S1P/S2P lipogenesis signal orchestrates the homeostasis and spatiotemporal activation of NF-kappaB[J].Cell Rep,2023,42:112586.doi: 10.1016/j.celrep.2023.112586.
[24] Hao K,Jiang W,Zhou M,et al.Erratum:Targeting BRD4 prevents acute gouty arthritis by regulating pyroptosis:Erratum[J].Int J Biol Sci,2025,21:473-474.

甾醇调控元件结合蛋白(SREBP)在代谢性炎症综合征中的研究进展

Research progress on the mechanism of action of sterol regulatory element-binding protein(SREBP) in metabolic inflammatory syndrome

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 13

编辑推荐

Metrics

本文评价

[1]	金磊, 吴茜茜, 张晓敏, 郭洁, 王锋. 饮食治疗痛风与高尿酸血症的研究进展[J]. 基础医学与临床, 2025, 45(3): 382-389.
[2]	王一博, 狄虹, 张小涵, 张昀, 曾学军. IL-17A促进慢性痛风性关节炎中破骨细胞形成[J]. 基础医学与临床, 2025, 45(12): 1608-1613.
[3]	王一博, 韩迎东, 谢天歌, 武娟, 狄虹, 张昀, 曾学军. 24例肩部关节痛风患者的临床特点[J]. 基础医学与临床, 2025, 45(11): 1485-1490.
[4]	赵紫琴, 董淑慧, 尹海波, 刘爱东, 杨勇, 熊光宜. siRNA沉默锌指蛋白A20基因促进人类风湿关节炎成纤维细胞样滑膜细胞焦亡[J]. 基础医学与临床, 2024, 44(10): 1407-1413.
[5]	杨丽娟, 董秋梅, 吴昊. ABCG2和SLC2A9在高尿酸血症和痛风发病中作用的研究进展[J]. 基础医学与临床, 2023, 43(9): 1467-1471.
[6]	高源, 郑刚, 齐靖, 张凤. NLRP3炎性小体在心脏病发病中的作用研究进展[J]. 基础医学与临床, 2023, 43(7): 1162-1166.
[7]	录亚鹏, 谢建琴. NLRP3炎性小体在缺血再灌注损伤治疗中作用的研究进展[J]. 基础医学与临床, 2023, 43(4): 706-710.
[8]	代志新, 王玉敏. NLRP3炎性小体在高尿酸血症肾病中作用的研究进展[J]. 基础医学与临床, 2023, 43(2): 322-326.
[9]	韦碧薇, 龚雅慧, 苏州, 杨慧莹, 覃蒙斌, 梁志海. miR-125b参与TRAF6影响的人胰腺导管上皮屏障作用[J]. 基础医学与临床, 2021, 41(9): 1272-1276.
[10]	郭艳芹, 殷博凯, 张娟, 何治. NLRP3炎性小体在脑缺血再灌注中的作用[J]. 基础医学与临床, 2021, 41(1): 120-124.
[11]	周永婷, 叶菜英, 朱蕾. NLRP3炎性小体激活调控机制及抑制剂研究新进展[J]. 基础医学与临床, 2020, 40(8): 1113-1118.
[12]	董鹏, 刘伟, 满斯亮, 李宏超, 王丽芳, 宋慧. 痛风急性发作所致发热患者临床特点分析[J]. 基础医学与临床, 2020, 40(11): 1519-1522.
[13]	黄晨恺甘达凯张望罗方云陈江汪安江李弼民朱萱. 熊果酸对肝纤维化大鼠NOX2/ROS/NLRP3炎性小体活化的影响[J]. 基础医学与临床, 2018, 38(4): 485-491.